Cargando…
Psammaplysins: Insights from Natural Sources, Structural Variations, and Pharmacological Properties
Marine natural products (MNPs) continue to be in the spotlight in the global drug discovery endeavor. Currently, more than 32,000 structurally diverse secondary metabolites from marine sources have been isolated, making MNPs a vital source for researchers to look for novel drug candidates. The marin...
Autores principales: | Youssef, Diaa T. A., Shaala, Lamiaa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693029/ https://www.ncbi.nlm.nih.gov/pubmed/36354986 http://dx.doi.org/10.3390/md20110663 |
Ejemplares similares
-
Cytotoxic Psammaplysin Analogues from the Verongid Red Sea Sponge Aplysinella Species
por: Shaala, Lamiaa A., et al.
Publicado: (2019) -
Psammaceratin A: A Cytotoxic Psammaplysin Dimer Featuring an Unprecedented (2Z,3Z)-2,3-Bis(aminomethylene)succinamide Backbone from the Red Sea Sponge Pseudoceratina arabica
por: Youssef, Diaa T. A., et al.
Publicado: (2021) -
Secondary Metabolites of the Genus Didemnum: A Comprehensive Review of Chemical Diversity and Pharmacological Properties
por: Youssef, Diaa T. A., et al.
Publicado: (2020) -
Total Synthesis of
the Dihydrooxepine-Spiroisoxazoline
Natural Product Psammaplysin A
por: Paciorek, Jan, et al.
Publicado: (2022) -
Identification and Bioactivity of Compounds from the Fungus Penicillium sp. CYE-87 Isolated from a Marine Tunicate
por: Shaala, Lamiaa A., et al.
Publicado: (2015)